Pfizer in talks to merge off-patent drugs business with Mylan <!-- no image --> <div>Pfizer Inc is in talks to merge its off-patent drugs business with Mylan NV in a stock deal, the Wall Street Journal reported on Saturday, citing people familiar with the matter.<div class="feedflare"> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=qMZYGeZsiX0:HmfFaAIYxXA:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?d=yIl2AUoC8zA" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=qMZYGeZsiX0:HmfFaAIYxXA:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=qMZYGeZsiX0:HmfFaAIYxXA:V_sGLiPBpWU" border="0"></a> <a href="http://feeds.reuters.com/~ff/reuters/UKBankingFinancial?a=qMZYGeZsiX0:HmfFaAIYxXA:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/reuters/UKBankingFinancial?i=qMZYGeZsiX0:HmfFaAIYxXA:F7zBnMyn0Lo" border="0"></a> </div><img src="http://feeds.feedburner.com/~r/reuters/UKBankingFinancial/~4/qMZYGeZsiX0" height="1" width="1" alt=""></div> Posted by Reuters